Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization

Fertility and Sterility

Volumn 78, Issue 5, 2002, Pages 1049-1054

  Commenges Ducos, Monique ^a   Piault, Stéphanie ^b   Papaxanthos, Aline ^a   Ribes, Claude ^a   Dallay, Dominique ^a   Commenges, Daniel ^b  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b Institut National pour la Santé et la Recherche Medicale U 330   (France)

Author keywords

Controlled ovarian hyperstimulation; Embryo; IVF ET; LH; Logistic regression; Ongoing pregnancy; Oocyte; Recombinant FSH

Indexed keywords

HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CONTROLLED STUDY; EMBRYO; EMBRYO INDUCTION; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR PHASE; HUMAN; HUMAN CELL; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; PROBABILITY;

ADULT; COHORT STUDIES; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; FOLLICULAR PHASE; HUMANS; MENOTROPINS; MODELS, STATISTICAL; ODDS RATIO; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 0036842329     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03372-1     Document Type: Article

References (27)

1. Filicori M. The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil Steril. 71:1999;404-414.
2. Fleming R., Lloyd F., Herbert M., Fenwick J., Griffith T., Murdoch A. Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone. Hum Reprod. 13:1998;1788-1792.
3. Westergaard L.G., Laursen S.B., Andersen C.Y. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophique women undergoing assisted reproduction. Hum Reprod. 15:2000;1003-1008.
4. Fleming R., Rehka P., Despande N., Jamieson M.E., Yates R.W.S., Lyall H. Suppression of LH during ovarian stimulation effects differ in cycles stimulated with purified urinary FSH and recombinant FSH . Hum Reprod. 15:2000;1440-1445.
5. Esposito M.A., Barnhart K.T., Coutifaris C., Patrizio P. Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone. Fertil Steril. 75:2001;519-524.
6. Sungurtekin U.S., Jansen R.P.S. Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril. 63:1995;663-665.
7. Hoff J.D., Quigley M.E., Yen S.S.C. Hormonal dynamics at midcycle a reevaluation . J Clin Endocrinol Metab. 57:1983;792-796.
8. Hershlag A., Kaplan E.H., Loy R.A., DeCherney A.H., Lavy G. Heterogeneity in patient populations explains differences in in vitro fertilization programs. Fertil Steril. 56:1991;913-917.
9. Ecochard R., Clayton D.G. Multivariate parametric random effect regression models for fecundability studies. Biometrics. 56:2000;1023-1029.
10. Commenges-Ducos M., Tricaud S., Papaxanthos-Roche A., Dallay D., Horovitz J., Commenges D. Modelling of the probability of success of the stages of in-vitro fertilization and embryo transfer stimulation, fertilization and implantation . Hum Reprod. 13:1998;78-83.
11. Diczfaluzy E., Harlin J. Clinical-pharmacological studies on human menopausal gonadotrophin. Hum Reprod. 3:1988;21-27.
12. Balasch J., Miro F., Burzaco I., Casamitjana R., Civico S., Ballesca J.L., et al. The role of luteinizing hormone in human follicle development and oocyte fertility evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating-hormone . Hum Reprod. 10:1995;1678-1683.
13. Schoot D.C., Coelingh-Bennink H.J.T., Mannaerts B.M.J.L., Lamberts S.W.J., Bouchard P., Fauser B.C.J.M. Human recombinant follicle-stimulating hormone induced growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotrophin deficiency. J Clin Endocrinol Metab. 74:1992;1471-1473.
14. European Recombinant Human LH Study Group . Recombinant human luteinizing hormone (LH) to support recombinant human follicular stimulating hormone (FSH) induced follicular development in LH and FSH deficiency anovulatory women a dose finding study . J Clin Endocrinol Metab. 83:1998;1507-1514.
15. Westergaard L.G., Erb K., Laursen S.B., Rasmussen P.E., Rex S. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in vitro fertilization in down-regulated normogonadotrophic women. Hum Reprod. 11:1996;1209-1213.
16. Strehler E., Abt M., El-Danasouri I., De Santo M., Sterzik K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotrophins on in vitro fertilization outcome. Fertil Steril. 75:2001;332-336.
17. Rahon A., Lavery S., Aurell R., Trew G., Margara R., Winston R. Clinical experience with recombinant follicle-stimulating hormone (FSH) and urinary FSH a retrospective case-controlled analysis . Fertil Steril. 75:2001;920-925.
18. Balasch J., Vidal E., Peñarrubia J., Casamitjana R., Carmona F., Creus M., et al. Suppression of LH during ovarian stimulation analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH . Hum Reprod. 16:2001;1636-1643.
19. Ganirelix Dose-Finding Study Group . A double-blind, randomized dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). Hum Reprod. 13:1998;3023-3031.
20. Westergaard L.G., Erb K., Laursen S.B., Rex S., Rasmussen P.E. Human menopausal gonadotrophin versus recombinant follicle-stimulating hormone in normogonadotrophic women down-regulated with a gonadotrophin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection a prospective randomized study . Fertil Steril. 76:2001;543-549.
21. Yamoto M., Shima K., Nakano R. Gonadotrophin receptors in human ovarian follicles and corpa lutea throughout the menstrual cycle. Horm Res. 37:1992;5-11.
22. Verpoest W.M.J.A., Cahill D.J., Harlow C.R., Hull M.G.R. Relationship between midcycle luteinizing hormone surge quality and oocyte fertilization. Fertil Steril. 73:2000;75-77.
23. Weston A.M., Zelinski-Wooten M.B., Hutchison J.S., Stouffer R.L., Wolf D.P. Developmental potential of embryos produced by in vitro fertilization from gonadotrophin-releasing hormone antagonist treated macaques stimulated with recombinant human follicle stimulating hormone alone or in combination with luteinizing hormone. Hum Reprod. 11:1996;608-613.
24. Adonakis G., Deshpande N., Yates R.W.S., Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotrophin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril. 69:1998;450-453.
25. Wu T.C., Wang L., Wan Y.J. Detection of estrogen receptor messenger ribonucleic acid in human oocytes and cumulus-oocyte complexes using reverse transcriptase-polymerase chain reaction. Fertil Steril. 59:1993;54-59.
26. Enmark E., Pelto-Huikko M., Grandien K., Lagercrantz S., Lagercrantz J., Fried G., et al. Human estrogen receptor β-gene structure, chromosome localization and expression pattern. J Clin Endocrinol Metab. 82:1997;4258-4265.
27. Filicori M., Cognigni G.E. Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction. J Clin Endocrinol Metab. 86:2001;1437-1441.